Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Bullboard Posts
Post by threefiftynineon Jun 02, 2020 9:00am
82 Views
Post# 31100544

-------GIVE YOUR HEADS A SHAKE---

-------GIVE YOUR HEADS A SHAKE---
This private placement is all about greed and greed always wins for bods and their buds . The pp will not be altered or cancelled. Its a done deal at .085 and along with the warrant IF this company have the goods they will all be very very wealthy people down the road and retail will have moved on to their next flavour of the week stock with their little profits .----I have been vocal in my comments about how the ceo of vaxil goes about public corporate business as I did with pump , huge and grat where corporate crooks screwed retail and continue to do just that. This company badly needs to speak and if they are holding back news until the .085 gets approved then they are at the same level as the above company management. Good clinical trial or funding news right now would propel the share price to mid-teens minimum and make a complete mockery of the priced pp...Look no further than that being the reason they are silent and it may well be illegal. Keep your eyes peeled on SEDI
Bullboard Posts